Publications

You can use the filters to show only results that match your interests

Filter publications
232 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Field safety notices: information from medical device manufacturers

    • MHRA
    • Notice
  2. Early access to medicines scheme (EAMS) scientific opinion: sacubitril/valsartan

  3. Reproduce or re-use MHRA information

    • MHRA
    • Guidance
  4. Suspended and revoked licences for manufacturers and wholesalers of medicines

  5. Medicines: company-led recalls

    • MHRA
    • Notice
  6. Register of brokers authorised to deal in human medicines

  7. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2015 to 2016

    • MHRA
    • Transparency data
  8. Medicines: licensing time-based performance measures

    • MHRA
    • Statistics
  9. Parallel import licences granted in July 2015

  10. Marketing authorisations granted in July 2015

  11. Advertising investigations: July 2015

  12. Human and veterinary medicines: register of licensed wholesale distribution sites

  13. Human and veterinary medicines: register of licensed manufacturing sites 2015

  14. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  15. Medicines: new manufacturing and wholesale dealer licences

  16. MHRA enforces European Commission decision to suspend medicines for which authorisation based on clinical studies conducted at GVK Biosciences

    • MHRA
    • Decision
  17. Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2014 - 2015

    • MHRA
    • Transparency data
  18. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  19. Alteplase for treatment of acute ischaemic stroke: independent review

    • MHRA
    • Decision
  20. Medicines and Healthcare products Regulatory Agency annual report and accounts 2014 to 2015

    • MHRA
    • Corporate report
  21. Human Medicines Regulations 2012 Advisory Bodies annual report 2014

    • MHRA
    • Corporate report
  22. Advertising investigations: June 2015

  23. Marketing authorisations granted in June 2015

  24. Parallel import licences granted in June 2015

  25. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  26. Annual reports of the ABRHP and the HMAC

    • MHRA
    • Corporate report
  27. Expert clinical advice – MHRA medical devices independent review: report on progress

    • MHRA
    • Corporate report
  28. Medicines and Healthcare products Regulatory Agency Business Plan 2015 to 16

    • MHRA
    • Corporate report
  29. Proposal to allow wider access to naloxone for use in emergencies

    • MHRA
    • Closed consultation
  30. Marketing authorisations granted in May 2015

  31. Parallel import licences granted in May 2015

  32. Advertising investigations: April 2015

  33. Annual review of good clinical practice referrals: 2011 to 2014

  34. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Statistics
  35. Parallel import licences granted in April 2015

  36. Marketing authorisations granted in April 2015

  37. Advertising investigations: March 2015

  38. Advertising investigations: February 2015

  39. Quarterly reports on the import of unlicensed medicines

    • MHRA
    • Statistics
  40. Field safety notice (FSN): what it is and why it's important

    • MHRA
    • Guidance